Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Sinovac Biotech, Ltd. (SVA) had Current Assets of $6.62B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
|
Current Assets |
$6.62B |
$697.07M |
|
$1.51B |
|
$8.14B |
|
$1.09B |
|
$233.12M |
|
$582.73M |
|
$1.67B |
|
$6.46B |
|
$6.37B |
|
$6.46B |
|
-- |
|
| Cash Flow Statement Financials | |
$-321.77M |
|
$315.06M |
|
$-152.24M |
|
$1.16B |
|
$998.55M |
|
$-157.88M |
|
-- |
|
$-25.22M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|